Datatrak grows revenues, op income & backlog in Q2

By Nick Taylor

- Last updated on GMT

Related tags Datatrak Income Income statement

Datatrak has posted an operating profit, grown revenues and recorded the forth consecutive quarter-on-quarter increase in backlog in its latest results.

Revenue in the second quarter was $1.9m (€1.5m), a year-on-year increase of three per cent. However, this is still down on the performance in the second quarter of 2008, when Datatrak generated revenue of $2.2m.

Sales growth in the second quarter helped Datatrak record an operating profit of $27,290. In the corresponding period of 2009 Datatrak posted an operating loss of $36,181, primarily as a result of severance expenses.

Datatrak also continued to grow its backlog. As of June 30 backlog was $10.9m, up year-on-year by 27 per cent. However, this is again lower than historic levels, such as the $13.2m backlog Datatrak had on June 30 2008.

Despite this, Laurence Birch, chairman of the Datatrak board, was bullish about the company’s prospects. He said: “The word is getting out that Datatrak is back in the game, as evidenced by the significant increase in traffic through our booth at the recent DIA meeting​.”

At DIA Datatrak generated 500 qualified leads, said Birch, and it also exhibited at the 2010 ASCO annual meeting and presented at the 2010 OneMedForum as part of continued marketing efforts.

In the second quarter Datatrak expanded its strategic partnership in Japan with NTT Data. The revised partnership allows NTT to sell enterprise transfer services in Japan and has entered into its first agreement in this area, generating additional revenues for both partners.

Datatrak has also inked a deal with its first Portuguese client, Keypoint Scientific Consultancy, and been selected by Daiichi Sankyo for a cardiovascular trial in Europe. Daiichi will use Datatrak’s eClinical platform for the trial, which spans 80 sites and 1,200 patients.

Related news

Show more

Related products

show more

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars